Abstract | BACKGROUND:
Dementia is one of the milestones of advanced Parkinson's disease (PD), with its neuropathological substrate still being a matter of debate, particularly regarding its potential mechanistic implications. OBJECTIVE: METHODS: We reviewed studies conducted at the Queen Square Brain Bank, Institute of Neurology, University College London, using large PD cohorts. RESULTS: Cortical Lewy- and Alzheimer-type pathologies are associated with milestones of poorer prognosis and with non- tremor predominance, which have been, in turn, linked to dementia. The combination of these pathologies is the most robust neuropathological substrate of PD-related dementia, with cortical Aβ burden determining a faster progression to dementia. CONCLUSION: The shared relevance of these pathologies in PD progression and dementia is in line with experimental data suggesting synergism between α- synuclein, tau and Aβ and with studies testing these proteins as disease biomarkers, hence favouring the eventual testing of therapeutic strategies targeting these proteins in PD.
|
Authors | Yaroslau Compta, Laura Parkkinen, Peter Kempster, Mariana Selikhova, Tammaryn Lashley, Janice L Holton, Andrew J Lees, Tamas Revesz |
Journal | Neuro-degenerative diseases
(Neurodegener Dis)
Vol. 13
Issue 2-3
Pg. 154-6
( 2014)
ISSN: 1660-2862 [Electronic] Switzerland |
PMID | 24028925
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid beta-Peptides
- alpha-Synuclein
- tau Proteins
|
Topics |
- Amyloid beta-Peptides
(metabolism)
- Brain
(metabolism, pathology)
- Dementia
(etiology, metabolism, pathology)
- Disease Progression
- Humans
- Parkinson Disease
(complications, metabolism, pathology)
- Retrospective Studies
- alpha-Synuclein
(metabolism)
- tau Proteins
(metabolism)
|